capecitabine has been researched along with CACH Syndrome in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Shahin, FI; Brown, EN; Liu, L | 1 |
| Duprez, T; Hanseeuw, B; Jacobs, S; Mossakowski, M; Van Marcke, C | 1 |
| Bayram, E; Bicakci, S; Demir, T; Iscan, D; Tolay, R | 1 |
| Gao, JL; Ong, CS; Tan, YJ | 1 |
| Hanssen, H; Heldmann, M; Münte, TF; Wagner-Altendorf, TA | 1 |
| Berzero, G; Bihan, K; Bompaire, F; Combret, S; Houillier, C; Jomier, F; Leclercq, D; Mahé, J; Perrain, V; Psimaras, D; Ricard, D | 1 |
| Dormont, D; Galanaud, D; Law-Ye, B; Leclercq, D; Obadia, M; Psimaras, D; Pyatigorskaya, N; Sahli-Amor, M; Wasserman, J | 1 |
| Daga, H; Inoue, M; Tokunaga, S; Yoshimura, K | 1 |
| Batty, R; Obeda, MS; Sharrack, B; Yasiry, Z | 1 |
| Iorio, R; Luigetti, M; Nicoletti, T; Spagni, G | 1 |
| Endo, A; Nakashima, R; Takahashi, N; Tanabe, K; Yoshida, Y | 1 |
| Goto, N; Mimura, J | 1 |
| Ban, T; Ikegaya, Y; Isogai, N; Kawachi, J; Miyake, K; Ogino, H; Shimoyama, R; Watanabe, K | 1 |
| McAdory, LE; Tan, MB | 1 |
| Ishikawa, T; Tukamoto, Y; Yasaki, S; Yoshii, F; Yuasa, N | 1 |
4 review(s) available for capecitabine and CACH Syndrome
| Article | Year |
|---|---|
Capecitabine-induced leukoencephalopathy in a patient with triple-negative breast cancer: A case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Leukoencephalopathies; Triple Negative Breast Neoplasms | 2022 |
Leukoencephalopathy with transient splenial lesions related to 5-fluorouracil or capecitabine.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Fluorouracil; Humans; Leukoencephalopathies; Retrospective Studies | 2021 |
Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Cardiomyopathies; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leukoencephalopathies; Male; Middle Aged; Shock, Cardiogenic | 2013 |
[Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
Topics: Acute Disease; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorouracil; Humans; Leukoencephalopathies; Middle Aged | 2014 |
12 other study(ies) available for capecitabine and CACH Syndrome
| Article | Year |
|---|---|
Acute leukoencephalopathy and thyroiditis induced by capecitabine.
Topics: Capecitabine; Humans; Leukoencephalopathies; Thyroiditis | 2022 |
Capecitabine-related neurotoxicity presenting with agraphia.
Topics: Adult; Agraphia; Capecitabine; Dysarthria; Fluorouracil; Humans; Leukoencephalopathies; Male | 2023 |
Capecitabine related neurotoxicity: Clinical and radiologic features.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies | 2022 |
Permanent lesion to the corticospinal tract after therapy with capecitabine.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Diagnosis, Differential; Fatal Outcome; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Middle Aged; Motor Neuron Disease; Pneumonia, Aspiration; Pyramidal Tracts; Quadriplegia | 2019 |
Capecitabine-induced acute toxic leukoencephalopathy.
Topics: Antimetabolites, Antineoplastic; Bone and Bones; Breast Neoplasms; Capecitabine; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Middle Aged; Pyramidal Tracts | 2017 |
Capecitabine-induced Leukoencephalopathy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Diffusion Magnetic Resonance Imaging; Female; Humans; Leukoencephalopathies; Middle Aged; Prodrugs | 2019 |
Capecitabine leukoencephalopathy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Humans; Leukoencephalopathies; Male; Middle Aged | 2019 |
Teaching NeuroImages: Transient mutism associated with splenium lesion in capecitabine-induced leukoencephalopathy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Corpus Callosum; Diffusion Magnetic Resonance Imaging; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Middle Aged; Mutism; Pyramidal Tracts; Stomach Neoplasms; Tomography, X-Ray Computed | 2019 |
Gastrointestinal: bevacizumab-induced reversible posterior leukoencephalopathy syndrome in patient with rectal cancer.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Deoxycytidine; Drug Substitution; Fluorouracil; Humans; Leukoencephalopathies; Male; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Syndrome | 2014 |
Capecitabine: toxic encephalopathy.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Humans; Leukoencephalopathies; Neurotoxicity Syndromes | 2015 |
Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Diagnosis, Differential; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Pyramidal Tracts; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2016 |
[Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Female; Fluorouracil; Humans; Leukoencephalopathies; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged | 2012 |